Skip to main content
50°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
General
Briefs
From
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Tickers
AZN
CINC
ENDP
HCM
Tags
Market News
TCON
CINC
From
Benzinga
AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States
August 08, 2022
Tickers
AZN
Tags
Analyst Rating
News
AZN
From
Best Stocks
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
Tickers
AZN
MRNA
PFE
VALN
Tags
Briefs
News
COVID/19 Coronavirus
From
Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
Tickers
AZN
EVO
KTTA
MRK
Tags
AZN
Biotech
NVS
From
Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
August 08, 2022
Tickers
AZN
AZNCF
HCM
Tags
General
Briefs
News
From
Benzinga
3 Unstoppable Stocks That Don't Care About the Bear Market
August 07, 2022
Tickers
ABBV
AZN
BMY
Tags
ABBV
Recent Press Releases
BMY
From
Motley Fool
Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal
August 05, 2022
Tickers
ABBV
AZN
BMY
JNJ
Tags
LLY
PFE
JNJ
From
MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
Tickers
ARQT
ATXS
AZN
MRK
Tags
PLSE
Benzinga
FDA
From
Benzinga
Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs
August 04, 2022
Tickers
AZN
AZNCF
LLY
PIRS
Tags
Market News
AZNCF
LLY
From
Benzinga
AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy
August 04, 2022
Tickers
AZN
MRK
Tags
AZN
EC Approval
MRK
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
AUPH
CCXI
PSTX
From
Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
August 02, 2022
Tickers
AZN
EBS
JNJ
Tags
Health Care
Biotech
Small Cap
From
Benzinga
Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody
August 01, 2022
Tickers
AVTX
AZN
Tags
AZN
Biotech
Contracts
From
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Tickers
ALXO
ARQT
AZN
BEAM
Tags
ARQT
Health Care
KZIA
From
Benzinga
AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer
August 01, 2022
Tickers
AZN
AZNCF
IPHA
Tags
Trading Ideas
Penny Stocks
Benzinga
From
Benzinga
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
July 31, 2022
Tickers
AMGN
AZN
Tags
AZN
Market News
Recent Press Releases
From
Motley Fool
3 Stocks We Think Could Beat the Market in the Second Half of 2022
July 30, 2022
Tickers
ABBV
AZN
JNJ
Tags
Market News
JNJ
AZN
From
Motley Fool
AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate
July 29, 2022
Tickers
AZN
AZNCF
MRNA
Tags
Benzinga
Market News
AZNCF
From
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
FDA
Trading Ideas
Financing
From
Benzinga
Recap: AstraZeneca Q2 Earnings
July 29, 2022
Tickers
AZN
Tags
News
AZN
BZI/Recaps
From
Benzinga
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29
July 29, 2022
Tickers
AAPL
AMZN
AZN
BABA
Tags
News
GOOG
TTM
From
Benzinga
AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance
July 29, 2022
Tickers
AZN
AZNCF
Tags
Benzinga
Trading Ideas
Market News
From
Benzinga
Earnings Scheduled For July 29, 2022
July 29, 2022
Tickers
AB
ABBV
ABR
ABTX
Tags
MGA
IPA
ECVT
From
Benzinga
$100 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
July 28, 2022
Tickers
AZN
Tags
Dividends
Benzinga
BZI/POD
From
Benzinga
FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review
July 25, 2022
Tickers
AZN
Tags
News
AZN
Biotech
From
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Tickers
AZN
DSNKY
ENVB
IBB
Tags
Financing
Trading Ideas
VTVT
From
Benzinga
U.S. Stock Futures Higher; Crude Oil Rises 1%
July 25, 2022
Tickers
AZN
FRD
PKG
REVB
Tags
TRV
PKG
Market News
From
Benzinga
Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments
July 25, 2022
Tickers
AZN
AZNCF
Tags
Large Cap
Biotech
AZN
From
Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
July 24, 2022
Tickers
AAPL
ABBV
AZN
BA
Tags
GE
CMCSA
TXN
From
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.